Cited by 12Thyroid Disorders and TreatmentsPituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Interactions between hypothalamic pituitary thyroid axis and other pituitary dysfunctions

Feldt-Rasmussen, Ulla, Klose, Marianne, Benvenga, Salvatore·2018·Endocrine

Abstract

Central hypothyroidism is defined as low circulating free thyroxine (free T4) with inappropriately low circulating thyrotropin (TSH), in context of a hypothalamic pituitary pathology. Rare cases of idiopathic central hypothyroidism caused by a functional defect may occur, and the condition is often overlooked due to difficulty in achieving the correct diagnosis, sparse symptomatology of the condition and a high risk of misinterpretion of the biochemical changes in central hypothyroidism. Central hypothyroidism is mainly seen in patients with hypothalamic-pituitary pathology due to one of many possible aetiologies, where other hormone deficiencies often co-exist, and both the presence of other deficiencies and their replacement have a strong influence on the measurement of the thyroid-related hormones and thereby interpretation of the thyroid function variables in relation to the clinical impact of thyroid hormone substitution therapy. Conversely, lack of thyroid hormone has a similar strong influence on the interpretation of other pituitary hormone axes, as well as their replacement. Undertreating patients with central hypothyroidism may have serious metabolic consequences with a potentially increased risk of cardiovascular morbidity. The present review thus aims at describing central hypothyroidism, by an overview of interactions of hypothyroidism with other pituitary hormones, diagnosing/testing for central hypothyroidism, and focusing on consequences of undertreatment. Finally, it is mentioned how to deal with new diagnostic settings with lower a priori likelihood of hypopituitarism, particularly in view of the importance of stringent diagnostic testing in order to avoid overdiagnosing central hypothyroidism.

Integrity signals

Registry

Crossref · 10.1007/s12020-018-1738-6

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Through acceleration of both thyroid hormone and cortisol metabolism, initiation of growth hormone replacement may unmask central hypothyroidism and hypoadrenalism; patients already under L-T4 replacement need increased L-T4 doses.

    “Through acceleration of both thyroid hormone and cortisol metabolism, initiation of growth hormone (GH) replacement may unmask CH and hypoadrenalism (82–84). Also, patients already under L-T4 replacement need increased L-T4 doses (82, 84).”

    From L-T4 therapy in the presence of pharmacological interferents (2020) · cites this paper as [82]

The citation lists haven’t been fetched yet

References 70 · Cited by 12

Authors
Feldt-Rasmussen, U., Klose, M., & Benvenga, S.
Affiliations
  • University of Copenhagen (DK)
  • University of Messina (IT)
Venue
Endocrine
Published
2018-09-06
Volume
62
Issue
3
Pages
519-527
ISSN
  • 0969-711X (ISSN-L)
  • 1355-008X
  • 1559-0100
OpenAlex
W2890454040
Cited by
12
References
70
Citations by year
2026: 1 · 2025: 4 · 2024: 2 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 1
FWCI
0.15
Type
journal article
Language
en
Open access
closed
Locations
  • Endocrine (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders
Novo Nordisk (No number)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
central hypothyroidism, hypothalamic-pituitary-thyroid axis, hypothalamic-pituitary dysfunction, hypopituitarism, thyroid-stimulating hormone, free thyroxine, thyroid hormone replacement, undertreatment, cardiovascular risk, misdiagnosis
MeSH terms
Humans, Hypopituitarism, Hypothalamo-Hypophyseal System, Pituitary Gland, Thyroid Function Tests, Thyroid Gland, Thyrotropin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review